Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.160.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.74EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.6.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.6.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.238EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.238EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DS.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
DS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.32EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.58EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.631EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.631EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.627EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.627EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.1.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.7.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.1.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.3.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.3.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.3.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.2.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.3.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LU.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LF.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LB.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.18.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used